baber/WOPTO huggingface dataset:
Patent DE-69901690-T2 (DE)
Inventor: GRESSENS PIERRE
IPC: A61K38/22
Filed: 1999-03-12
Granted: 2003-02-13
Abstract: The invention concerns a novel use of VIP analogues for preventing and/or treating brain damage in a human foetus, baby or infant. Said VIP analogue is selected from the group consisting of cyclic VIP analogues and non-cyclic VIP derivatives of 28 amino acids comprising in N-terminal position a N-acetyl group, then Glu in position 8 (Glu<8>), Lys in position 12 (Lys<12>), polyclonal goat in position 17 (Nle<17>), Ala in position 19 (Ala<19>), X1 in position 21, X2 in position 25, Leu in position 26 (Leu<26>), Lys in position 27 and 28 (Lys<27> and Lys<28>), Gly in position 29 and 30 (Gly<29> and Gly<30>) and Thr in position 31 (Thr<31>), X1 representing Lys (Lys<21>) or Nle (Nle<21>) and X2 representing Asp (Asp<25>) or Asn (Asn<25>).
Patent DE-69906302-T2 (DE)
Inventor: BESSE JEROME
IPC: A61K9/48
Filed: 1999-07-19
Granted: 2003-11-27
Abstract: The invention concerns a pharmaceutical composition designed to adhere to a mucous membrane for preventing or treating radiotherapy-related and chemotherapy-related mucositis, induced by radiotherapy or combined radiochemotherapy, comprising an effective amount of an antiradical compound mixed with a vehicle, which is liquid at room temperature and gels at the mucous membrane temperature and capable of adhering to the mucous membrane by its gelled status.
Patent DE-69907330-T2 (DE)
Inventor: LECRIVAIN ALAIN
IPC: B21B31/02
Filed: 1999-02-12
Granted: 2004-03-25
Abstract: PCT No. PCT/FR99/00322 Sec. 371 Date Dec. 3, 1999 Sec. 102(e) Date Dec. 3, 1999 PCT Filed Feb. 12, 1999 PCT Pub. No. WO99/41026 PCT Pub. Date Aug. 19, 1999A metal band product rolling installation comprising at least two rolls with parallel axes inside a fixed holding stand (1) having two separate standards (11a, 11b) each forming a closed frame comprising two stiles (12 12'), an upper crossbeam (16) and a lower crossbeam (16'), and delineating a center window (6), at least one of the rolls being a back-up roll (3), carried by two supporting parts (4a, 4b) each resting on a back-up face (63) of the corresponding crossbeam (16 16') of each standard (11a, 11b). According to the invention, at least on one side of the rolling plane (T1), the crossbeam (16) of each standard (11a, 11b) is fitted with a back-up face (63) exhibiting, over the whole width of the window (6), a concave rounded profile extending on an angular sector of at least 180 DEG  and the supporting part (4) of each end head (35a, 35b) of the back-up roll (3) rests on the said crossbeam (16) via a back-up part (42) delineated by a contact face (41) with a convex rounded profile matching that of the back-up face (63).
Patent DE-69907929-T2 (DE)
Inventor: PIRIM PATRICK
IPC: H04N7/50
Filed: 1999-08-26
Granted: 2004-05-13
Abstract: For the compression, preferably between a preliminary encoding, such as an encoding by a wavelet filter (11) and a compression in a compression-decompression assembly (13), as used in the system MPEG, there is a displacement encoding GVPP stage (12A) which generates, at the beginning of each sequence a frame of the video signal received and then, for each pixel, correction digital signals indicating a displacement for this pixel, with the quantified amplitude and oriented direction of the displacement, or a non-displacement, until global modification of the pixels marking the beginning of a new sequence and, for the decompression, preferably between a decompression in a compression-decompression assembly (13), of the type mentioned above, and a final decoding, such as performed in a reverse-operating wavelet filter (11), a displacement decoding assembly (12B), which, from a signal compressed by the compression mentioned above, transmits the frames of the beginning of each sequence and then replaces in position the pixels whose displacement is indicated by correction signals, while leaving in position the other pixels.
Patent DE-69912301-T2 (DE)
Inventor: KENNY PATRICK
IPC: G02B6/00
Filed: 1999-11-11
Granted: 2004-07-29
Abstract: Strain sensors, and in particular strain rosettes, are described and claimed, in which the strain sensing elements are fiber Bragg gratings. Strain sensors in accordance with the described invention comprise first and second fiber Bragg gratings, and a length of optical fiber connecting the gratings in series, each grating being substantially straight and the two gratings being non-parallel and having different nominal Bragg wavelengths, the connecting length of optical fiber having a bend, characterised in that a portion of the connecting length is tapered, the tapered portion including an elongate waist portion having a reduced cross sectional area and said bend is formed in the waist portion.
Patent DE-69915458-T2 (DE)
Inventor: GREEN HA
IPC: C08B37/02
Filed: 1999-03-25
Granted: 2005-02-24
Abstract: This disclosure describes pharmaceutical compositions and a method for treatment of joint inflammation and pain bought about by e.g. arthritis, physical trauma, bacterial or viral infection. In one embodiment, the method comprises administration of a bimodal molecular weight dextran formulation comprising 0.2 to 32% w/v of a dextran fraction with average molecular weight between 30,000 and 110,000 daltons and 0.2 to 6% dextran with an average molecular weight between 500 and 3,000 daltons, into the joint of a warm blooded animal.
Patent DE-69918616-T2 (DE)
Inventor: HIRANO TORU
IPC: A61F9/008
Filed: 1999-08-17
Granted: 2004-11-18
Abstract: An ophthalmic treatment apparatus uses therapy and diagnostic laser light sources (1,5) whose beams are deflected two-dimensionally via an optical deflector (8) and a galvanomirror (13) and directed on the eye fundus (16b) to produce a fundus image on a display monitor (26). A photosensitive substance that accumulates specifically in neovascular regions is administered to the patient to define the region where the neovascular tissues are located. When the region is to be treated, the therapy laser light source (1) is activated and its intensity is amplified by a controller (29) and a driver (28) for driving a light modulator (2). This arrangement assures a reliable definition of the affected region and enables only the neovascular tissues to be destroyed or sealed off because the laser intensity can be amplified at the region concerned. <IMAGE>
Patent DE-69922017-T2 (DE)
Inventor: BARROW W
IPC: A61K31/438
Filed: 1999-08-12
Granted: 2005-11-24
Abstract: A method of treating or preventing an intracellular infection in an animal comprising administering a first effective amount of a suitable drug contained in first biocompatible microspheres that have a diameter of less than or equal to about 10 microns, wherein the first microspheres release the suitable drug upon administration at a first effective rate. A second set of microspheres greater than 10 microns in diameter may also be administered to provide continuing systemic release of the drug.
Patent DE-69923982-T2 (DE)
Inventor: BROUARD REMI
IPC: A61P13/12
Filed: 1999-07-08
Granted: 2006-03-30
Abstract: The invention concerns a pharmaceutical composition containing in combination indomethacin and an antagonist of the angiotensin II AT1 receptors, in particular irbesartan and the use of said composition for treating chronic glomerulonephritis.
Patent DE-69924984-T2 (DE)
Inventor: PEDERSEN BJORN
IPC: C02F3/30
Filed: 1999-02-01
Granted: 2006-03-02
Abstract: A method and a plant (1) for biological treatment of waste water comprising a container (2) with a quantity of waste water containing a large number of separate carrying elements (8) kept enclosed in a riser pipe (5) placed vertically in the container. The carrying material is kept fluidised in the riser pipe by alternately blowing air in under the riser pipe and recirculating the water through this. The plant can easily and conveniently be placed as a unit in a container where the biological catabolism of organic material will be passing off effectively as aerobic and anaerobic conditions are alternately created in the biofilm. The plant is simple and compact and economical in use.
Patent DE-69935243-T2 (DE)
Inventor: STILBORN HEATHER L
IPC: A23L15/00
Filed: 1999-11-19
Granted: 2007-11-08
Abstract: The present invention provides a method of reducing cholesterol in animals and food products derived from such animals. The method includes feeding to the animals a low phytate food source so that the phytate phosphorus intake of the animal is reduced.
Patent DE-69935460-T2 (DE)
Inventor: LUBBERS LAWRENCE M
IPC: A61B17/11
Filed: 1999-10-18
Granted: 2007-11-08
Abstract: Apparatus and methods for repairing damaged tendons or ligaments. Various repair apparatus include an elongate tensile member (376) and a pair of anchor structures (390, 410) connected for movement along the tensile member (376) on either side of a repair site (370, 372), such as a tear or laceration. The anchor structures may take many forms, and may include barbed, helical, and crimp-type anchors (126, 390, 840). In the preferred embodiments, at least one anchor structure (390, 410) is movable along the elongate tensile member (376) to assist with adjusting a tendon segment (356) to an appropriate repair position and the anchor structure or structures (390, 410) are then lockable onto the elongate tensile member (376) to assist with affixing the tendon at the repair position. The invention further provides tendon-to-bone repair apparatus (250) and methods employing similar concepts. Tendon retrieval devices (750) of the invention include helical members (756) for rotating into a tendon end (752) and subsequently moving the tendon to an appropriate operating position.
Patent DE-69935722-T2 (DE)
Inventor: DAI JIN
IPC: G01S5/12
Filed: 1999-09-08
Granted: 2007-12-27
Abstract: The present invention is a system and method for accurately determining the distance (range) between one or more satellites and a user terminal and the rate of change (range rate) of that distance. When accurately determined according to the present invention, these quantities can be used to determine the location of the user terminal with a high degree of accuracy. When one satellite is available, the present invention determines the range and range rate based on the Doppler frequency shift that a signal experiences between the satellite and the user terminal, the round trip delay a signal experiences during transmission from the satellite to the user terminal and back via a satellite to a gateway, the Doppler frequency shift a signal experiences between the satellite and the gateway, and the timestamps of the measurements. When a second satellite is available, the present invention determines the range and range rate between the second satellite and the user terminal based on the round trip delay, the Doppler frequency shift that a signal experiences between the second satellite and the user terminal, and the difference in arrival times at the user terminal of the signals from the satellites.
Patent HU-E027266-T2 (HU)
Title: Use of SNS-595 for treating leukemia
Inventor: ADELMAN DANIEL C
IPC: F24S10/70
Filed: 2005-03-14
Abstract: The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound to the patient in a dose of 10 mg/m 2  to 100 mg/m 2 .
Patent HU-E027496-T2 (HU)
Title: Method for producing a functional layer of a building shell, and building shell and functional layer
Inventor: SCHROEER JOERN
IPC: E04D12/00
Filed: 2010-03-25
Abstract: The invention relates to a method for producing a functional layer of a building shell (2), wherein the building shell (2) has a shuttering (11) on the inside of the building and a majority of rafters (12) having rafter fields (14) provided between the rafters (12) and the shuttering (11). According to the present invention, it is provided that the functional layer is applied to the external side (15) of the shuttering (11) at least in some regions by way of painting and/or spraying, and after being applied thereto said functional layer forms an air and/or watertight foil (10), which is in particular designed as a vapor barrier.
Patent HU-E027399-T2 (HU)
Title: Angiotensin II receptor antagonist for the treatment of cardiovascular disease in cats
Inventor: STARK MARCUS
IPC: A61P9/00
Filed: 2007-10-04
Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
Patent HU-E031123-T2 (HU)
Title: Advanced multistep process for obtaining modified inorganic particles
Inventor: DICKE RENE
IPC: C09C3/00
Filed: 2013-09-03
Abstract: The present invention relates to a process for obtaining modified inorganic particles having a layered structure comprising the steps of a1) Providing an organic and/or aqueous solution or suspension comprising at least one first amino compound in a first vessel T1 and protonating the at least one first amino compound by using at least one acid; b) Providing a homogenous suspension comprising at least one inorganic particle having a layered structure in an organic or a mixture of water and at least one organic solvent in a second vessel T2; c1) addition of the solution or suspension of the at least one first protonated amino compound from the first vessel T1 to the homogenous suspension comprising at least one inorganic particle having a layered structure in the second vessel T2; and d) removal and work up of the modified inorganic particles.
Patent HU-E025746-T2 (HU)
Title: Estrogen receptor modulators and uses thereof
Inventor: SMITH NICHOLAS D
IPC: A61P35/00
Filed: 2011-09-15
Abstract: A compound that has the structure of Formula (XII):
   
wherein, 
X 1  is CH, CR 3  or N; 
X 2  is N, CH, or CR 3 ; 
Z is -OH or -OR 10 ; 
R 2  is C 1 -C 4 alkyl, C 1 -C 4 fluoroalkyl, C 1 -C 4 deuteroalkyl, C 3 -C 6 cycloalkyl, or -C 1 -C 4 alkylene-W; 
W is hydroxy, halogen, CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, and C 3 -C 6 cycloalkyl; 
each R 3  is independently halogen, C 1 -C 4 alkyl, or C 1 -C 4 fluoroalkyl; 
each R 4  is independently halogen, -CN, -OR 9 , -S(=O) 2 R 10 , C 1 -C 4 alkyl, C 1 -C 4 fluoroalkyl, or C 1 -C 4 heteroalkyl; 
each R 5  is independently halogen, -CN, -OR 9 , -S(=O) 2 R 10 , C 1 -C 4 alkyl, C 1 -C 4 fluoroalkyl, or C 1 -C 4 heteroalkyl; 
R 6  is H, C 1 -C 4 alkyl, or halogen; 
R 7  is H, C 1 -C 4 alkyl, or halogen; 
R 9  is H, C 1 -C 6 alkyl, C 1 -C 6 fluoroalkyl, or C 3 -C 6 cycloalkyl; 
R 10  is C 1 -C 6 alkyl; 
m is 0, 1, or 2; 
n is 0, 1, 2, 3, or 4; and 
p is 0, 1, or 2; 
or a pharmaceutically acceptable or N-oxide thereof.
Patent HU-E031896-T2 (HU)
Title: Supporting transport diversity and time-shifted buffers for media streaming over a network
Inventor: FALL KEVIN ROLAND
IPC: H04W4/18
Filed: 2014-01-14
Abstract: A proxy unit is configured to obtain mapping information that maps an identifier for media data to a resource location based on a service for retrieving the media data, wherein the service defines at least one of a plurality of types of transports for transporting the media data, receive a request for the media data from an application service client, determine whether the service is available, and, when the service is available, cause the application service client to receive the media data from a unit that receives the media data using the service from the resource location, based on the mapping information. In this manner, the application service client may receive media data from the unit (e.g., a middleware unit), which then receives the media data using a service that defines transport according to, e.g., broadcast or multicast transport, or another fashion (e.g., unicast) if the defined transport is unavailable.
Patent TR-200003826-T2 (TR)
Title: Bis-fonksiyonel polisülfür silanlar kullanarak metallerdeki aşınmanın önlenmesi
Inventor: OOIJ WIM J VAN
IPC: C23C22/56
Filed: 1999-06-24
Abstract: Bis-foksiyonel polisülfür silanlar kullanilarak metallerin asinmasinin önlenmesi için bir yöntemdir. Yöntem bir metal yüzeyin saglanmasi, ve bir isleme çözeltisinin metal yüzey üzerine uygulanmasini içerir. Isleme çözeltisi en az bir formül (I) hidroliz edilmis bis-fonksiyonel polisülfür silan içerir; burada her bir R bir alkil veya bir aseti grubudur, ve Z ya -Sx veya -Q-Sx-Q-'dir, burada her bir Q bir alifatik veya aromatik gruptur, ve x 2 ila 9 arasinda bir tamsayidir. Ayrica bir islem çözeltisi ve daha iyi asinma direncine sahip metal yüzey de saglanmaktadir.
Patent TR-200101316-T2 (TR)
Inventor: GAGLIARDI LEO
IPC: C11D17/00
Filed: 1999-11-10
Abstract: The present invention provides a composition in the form of an aqueous emulsion comprising a diacyl peroxide and a surfactant system.
Patent TR-200103660-T2 (TR)
Title: Kardiyak aritmaların tedavisinde faydalı yeni bispidin bileşikleri
Inventor: FRANTSI MARIANNE
IPC: A61K31/435
Filed: 2000-06-15
Abstract: R1,R2,R3,R4,R5A,R5B,R6,R9,X,A VE B'nin tarifte verilen anlamlara geldigi, aritmalarin, özellikle de atriyal ve ventriküler aritmalarin tedavisinde ve profilaksiside faydali fomül (I)'e ait bilesikler saglanmistir.(Formül I)
Patent TR-200202110-T2 (TR)
Inventor: OE TAKAYUKI
IPC: A61P3/06
Filed: 1999-11-19
Abstract: The invention relates to type A crystal of 5-[{6-(2-fluorobenzyl)oxy-2-naphtyl}methyl]-2,4-thiazolidinedione characterized to have characteristic absorption peaks (2theta) at 11.5°±0.3°, 14.5°±0.2°, 16.2°±0.3°, 17.0°±0.3°, 17.7°±0.2°, 18.6°±0.3°, 19.1°±0.2°, 21.3°±0.4°, 22.4°±0.5°, 25.7°±1.5° and 28.3°±10.5° in a powder X-ray diffraction pattern, and also to a method for preparation thereof, and a pharmaceutical composition comprising the same. The crystal is excellent in stability, and has advantages in handling, storage, and pharmaceutical preparation. The invention also relates to type B, C and D crystals of said compound.
Patent TR-200402517-T2 (TR)
Title: HBV ilaç direnci tespit metotları
Inventor: BOZDAYI MITHAT ABDURRAHMAN
IPC: C07K14/02
Filed: 2002-03-29
Abstract: Buluş izole edilmiş bir HBV polinükleik asidi ya da onun bir parçasına ilişkin olup, özelliği, HBV ters transkriptaz alanının kodon 204'ünü içermesi, bu kodon 204'ün de bir serini kodlamasıdır. Mevcut buluş ayrıca, söz konusu DNA nükleik asit polimorfizmlerine ek olarak kullanılan oligonükleotidleri içeren HBV soylarının biyolojik bir örneğindeki güvenilir bir tespit için olan metotlarla ilgilidir. Buluş, ayrıca, HBV nükleik asit polimorfizmlerini içeren HBV varyantlarının antiviral bileşiklerine karşı hassasiyeti test eden metotlara ek olarak, HBV nükleik asit polimorfizmlerini içeren vektörlere ilişkindir.
Patent DE-602004012189-T2 (DE)
Inventor: KWON HWAN-JOON
IPC: H04W28/10
Filed: 2004-05-10
Granted: 2009-03-19
Abstract: Presented are a system and method for controlling data rates of a reverse packet data channel (R-PDCH) in a mobile communication system. A mobile station (MS) indicates a maximum possible data rate (RIS) to a base station (BS), whereupon a scheduler in the base station determines which data rate it will assign to the mobile station. The base station sends an indication of the assigned data rate (203) to the mobile station, causing the mobile station to adapt its data rate (217). Intermediate data rates can be jumped, thus improving the throughput of the mobile communication system. <IMAGE>
Patent DE-602005003858-T2 (DE)
Inventor: LEVORSE ANTHONY T JR
IPC: A61K8/37
Filed: 2005-01-27
Granted: 2008-12-11
Abstract: The use of 2-methyl-benzoic acid methyl ester as a fragrance chemical, suitable for use in creating fragrance, and scents in items such as perfumes, colognes and personal care products is disclosed.
Patent DE-602005004234-T2 (DE)
Inventor: O'REGAN TERRY
IPC: D04H3/016
Filed: 2005-11-08
Granted: 2009-01-08
Abstract: A nonwoven material which can be elongated and which will partially recover. The material comprises a web of fibers comprising polymeric chains which fibers are entangled with one another. The fibers are stretched in a first direction at a temperature wherein the fibers are aligned in a first direction and the polymeric chains within the fiber are also orientated in such first direction. The fibers are then cooled and demonstrate an ability to elongate and partially recover in a second direction that is different from the first direction.
Patent DE-602006000775-T2 (DE)
Inventor: FAVA ENRICO
IPC: A23L7/109
Filed: 2006-01-31
Granted: 2009-04-09
Abstract: A homogenising and kneading mixer comprising a premixer (12) placed upstream from a kneader and at least two kneading screws (20, 21) in turn connected with a vacuum tank (37) feeding final compression screws (44), in which the kneader has a containment cylinder (19a, 19b) and respective kneading screws (20, 21) realised in portions of different diameter, a first portion of smaller diameter (19a, 20a, 21a) arranged at a pasta scrap feeding conduit (25) and a second portion of greater diameter (19b, 20b, 21b) arranged at the premixer (12).
Patent DE-69911178-T3 (DE)
Inventor: HORY ARNAUD
IPC: B28B1/00
Filed: 1999-02-17
Granted: 2009-06-18
Abstract: A succession of superposed digitized sections of an object are produced from a three-dimensional representation of the object. A powder or a mixture of powders is spread in the form of a fine layer and heated to a temperature close to solid phase sintering temperature of the powder or the mixture of powders. The layer is brought to the sintering temperature by scanning with a laser beam the layer such that a selected part of the powder, corresponding to one of the digitized sections of the object to be produced, is sintered in solid phase by the additional energy supplied by the laser. Additional layers of the powder or the mixture of powders are spread, heated and scanned with the laser beam until all the digitized superposed sections of the object to be produced are obtained.
Patent DK-1170357-T3 (DK)
Inventor: BUERGER ADAM
IPC: C12M1/113
Filed: 2000-11-17
Granted: 2005-07-11
Abstract: Solids dosing device (6) consists of a feed shaft (7) for organic substances, a linear conveyor (8) connected to the base of the shaft and a conveyer tube (9). The linear conveyor presses organic substances into and through the conveyor tube. The conveyor tube is connected to the fermenter feed opening (15). Preferred Features: The conveyor tube ends with its outlet (13) in the upper fermenter inner region above and/or below the liquid mirror (14) and is bent with an outlet directed downwards below the liquid mirror. The conveyor tube is led through the fermenter feed opening in a side wall (3) of the fermenter container in the upper side wall region and
Patent DK-1180035-T3 (DK)
Inventor: POSNER GARY H
IPC: A61P3/02
Filed: 2000-03-31
Granted: 2007-03-05
Abstract: Novel sulfur-containing analogs of 1±,25-dihydroxyvitamin D 3  are provided. These analogs are synthesized in a convergent manner by joining A-ring and C,D ring fragments. Each analog with 1±,3²-substituent stereochemistry shows a pharmacologically desirable combination of high antiproliferative and high transcriptional activities  in vitro  and also low calcemic activity  in vivo.
Patent DK-1201322-T3 (DK)
Inventor: BRENNER AXEL
IPC: B06B1/06
Filed: 2001-09-13
Granted: 2010-05-17
Abstract: The method involves producing ceramic elements as piezoelectric or electrostrictive rods (20) with a constant thickness plastic coating, feeding them to a container (31) with a vibration drive to pack them vertically, filling the container with plastic, resin or polyurethane, removing the container after setting, grinding until the rods are at a length suitable for a working frequency and arranging electrodes to contact some or all rods. Independent claims are also included for the following: an ultrasonic transducer.